Discussion
schizophrenia, TargetFlame
TargetFlame combines a precision psychiatry and a drug repurposing approach in which patients with an inflammatory phenotype are selected and treated with an immunomodulatory drug. The immune hypothesis of schizophrenia (Muller Using Celecoxib for the proposed indication demands a detailed risk–benefit evaluation. Celecoxib has been approved and is indicated according to the 